» Articles » PMID: 39433699

Non Invasive Preimplantation Testing for Aneuploidies in Assisted Reproduction: A SWOT Analysis

Overview
Journal Reprod Sci
Publisher Springer
Date 2024 Oct 21
PMID 39433699
Authors
Affiliations
Soon will be listed here.
Abstract

The implementation of non-invasive PGT-A offers a new strategy to genetically assess the preimplantation embryo and to enhance IVF results. The extraction of DNA from the embryo culture medium has been sufficiently demonstrated, and the ability to obtain chromosomal information as a result is particularly interesting. As morphological criteria have proven to have a weak correlation with embryo ploidy status, this technique emerges as a promising alternative for embryo selection. It also appears reasonable that avoiding biopsy may enhance further embryo development. However, there are growing concerns regarding several aspects of this technique, such as the origin of this cell free DNA, the degree of representativeness of the whole embryo, the need for extended culture or the absence of standardized protocols. Despite the published data on good prognosis couples are promising, niPGT-A is yet to be considered a substitute for trophectoderm biopsy. The current SWOT analysis aims to summarize both resolved and unresolved issues, as well as limiting aspects of niPGT-A.

References
1.
Minasi M, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F . Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016; 31(10):2245-54. DOI: 10.1093/humrep/dew183. View

2.
Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G . Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014; 29(6):1173-81. DOI: 10.1093/humrep/deu033. View

3.
Barnes J, Brendel M, Gao V, Rajendran S, Kim J, Li Q . A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: a retrospective model development and validation study. Lancet Digit Health. 2022; 5(1):e28-e40. PMC: 10193126. DOI: 10.1016/S2589-7500(22)00213-8. View

4.
Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, Cottone G . Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril. 2014; 101(5):1375-82. DOI: 10.1016/j.fertnstert.2014.01.051. View

5.
Capalbo A, Ubaldi F, Cimadomo D, Maggiulli R, Patassini C, Dusi L . Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. Hum Reprod. 2015; 31(1):199-208. PMC: 4677968. DOI: 10.1093/humrep/dev294. View